As of 2026-09-21, the Relative Valuation of BetterLife Pharma Inc (BETR.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.36 CAD, the upside of BetterLife Pharma Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-09-14 | -26.30 |
| 2026-09-11 | -22.35 |
| 2026-09-10 | -20.05 |
| 2026-09-09 | -19.72 |
| 2026-09-08 | -20.05 |
| 2026-09-04 | -19.72 |
| 2026-09-03 | -19.72 |
| 2026-09-02 | -18.74 |
| 2026-09-01 | -19.07 |
| 2026-08-31 | -19.07 |
| 2026-08-28 | -20.71 |
| 2026-08-27 | -20.38 |
| 2026-08-26 | -24.33 |
| 2026-08-25 | -24.98 |
| 2026-08-24 | -21.04 |
| 2026-08-21 | -21.37 |
| 2026-08-20 | -20.71 |
| 2026-08-19 | -23.01 |
| 2026-08-18 | -23.67 |
| 2026-08-17 | -19.72 |
| 2026-08-14 | -18.74 |
| 2026-08-13 | -19.72 |
| 2026-08-12 | -20.71 |
| 2026-08-11 | -18.74 |
| 2026-08-10 | -20.05 |
| 2026-08-07 | -27.94 |
| 2026-08-06 | -26.30 |
| 2026-08-05 | -24.00 |
| 2026-08-04 | -23.67 |
| 2026-07-31 | -19.07 |
| 2026-07-30 | -15.78 |
| 2026-07-29 | -15.12 |
| 2026-07-28 | -15.12 |
| 2026-07-27 | -15.78 |
| 2026-07-24 | -13.81 |
| 2026-07-23 | -13.15 |
| 2026-07-22 | -15.12 |
| 2026-07-21 | -15.45 |
| 2026-07-20 | -15.12 |
| 2026-07-17 | -14.14 |
| 2026-07-16 | -14.79 |
| 2026-07-15 | -15.45 |
| 2026-07-14 | -13.15 |
| 2026-07-13 | -13.15 |
| 2026-07-10 | -12.82 |
| 2026-07-09 | -12.49 |
| 2026-07-08 | -12.49 |
| 2026-07-07 | -12.49 |
| 2026-07-06 | -12.49 |
| 2026-07-03 | -12.49 |